Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Scrip Awards
Partnered Content
Scrip 100
Scrip Asia 100
Report Store
Ask The Analyst
PItCH
PDF Library
RSS Feeds
Subscribe
Advertise
UsernamePublicRestriction
Tags:

Fujifilm’s Tender Offer for Toyama Chemical Begins (Part 1 Of 2)

This article was originally published in PharmAsia News

  • News

Executive Summary

TOKYO - Fujifilm Holding's tender offer for Japanese pharma Toyama Chemical started as scheduled on Feb. 19 and will last for one month. In a move that took many in the business industry by surprise, the top global photographic and imaging company declared its intent to move into the pharmaceutical business in a joint announcement with Toyama Chemical and Taisho Pharmaceutical, the top over-the-counter drug company in Japan and major shareholder of Toyama Chemical
Table

View full table

Advertisement

Related Content

Scrip
Fujifilm’s Tender Offer For Toyama Chemical Begins (Part 2 Of 2)
Scrip
Fujifilm’s Tender Offer For Toyama Chemical Begins (Part 2 Of 2)
Scrip
Analysis: Film-Maker Fujifilm To Enter Japan Drug Business with Toyama Chemical Acquisition
Advertisement
Tags:
UsernamePublicRestriction

Register

SC067723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By